Erythromycin Ethyl Succinate

琥乙红霉素

Report date: 2026/03/04 20:01:44

Base Information

Drug NameErythromycin Ethyl Succinate
Drug Alias NameErythromycin Ethylsuccinate琥珀酸乙酯红霉素Eryped
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Macrolides antibiotics
Mechanisms of Action50S ribosomal subunit inhibitors
Targets50S ribosomal subunit
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsBacterial Infections
Approved Indications in ChinaBacterial Infections
Original Approved Country/TerritoryUnited States
Original Approved Date1965/04/02
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAbbott Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesCarnegie Pharmaceuticals LLCHarbin Pharmaceutical Group Sixth Pharmaceutical Factory
Inactive CompaniesN/A
Active IndicationsBacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeD10AF02J01FA01S01AA17
Related LinksWikipediaDrugBankKEGG